PMC:7381711 / 16224-16607 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T141","span":{"begin":23,"end":30},"obj":"Body_part"},{"id":"T142","span":{"begin":140,"end":145},"obj":"Body_part"},{"id":"T143","span":{"begin":259,"end":266},"obj":"Body_part"}],"attributes":[{"id":"A141","pred":"fma_id","subj":"T141","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A142","pred":"fma_id","subj":"T142","obj":"http://purl.org/sig/ont/fma/fma7199"},{"id":"A143","pred":"fma_id","subj":"T143","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"Clinically, the use of heparin as an anti-inflammatory agent has shown limited evidence of benefit in human diseases including inflammatory bowel disease, asthma, reactive airways disease, and acute coronary syndrome (13, 24). Despite this clinical evidence, heparin has not been approved by the US Federal Drug Administration as a direct anti-inflammatory for any medical condition."}

{"project":"LitCovid-PubTator","denotations":[{"id":"576","span":{"begin":102,"end":107},"obj":"Species"},{"id":"577","span":{"begin":23,"end":30},"obj":"Chemical"},{"id":"578","span":{"begin":259,"end":266},"obj":"Chemical"},{"id":"579","span":{"begin":127,"end":153},"obj":"Disease"},{"id":"580","span":{"begin":155,"end":161},"obj":"Disease"},{"id":"581","span":{"begin":193,"end":216},"obj":"Disease"}],"attributes":[{"id":"A576","pred":"tao:has_database_id","subj":"576","obj":"Tax:9606"},{"id":"A577","pred":"tao:has_database_id","subj":"577","obj":"MESH:D006493"},{"id":"A578","pred":"tao:has_database_id","subj":"578","obj":"MESH:D006493"},{"id":"A579","pred":"tao:has_database_id","subj":"579","obj":"MESH:D015212"},{"id":"A580","pred":"tao:has_database_id","subj":"580","obj":"MESH:D001249"},{"id":"A581","pred":"tao:has_database_id","subj":"581","obj":"MESH:D054058"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Clinically, the use of heparin as an anti-inflammatory agent has shown limited evidence of benefit in human diseases including inflammatory bowel disease, asthma, reactive airways disease, and acute coronary syndrome (13, 24). Despite this clinical evidence, heparin has not been approved by the US Federal Drug Administration as a direct anti-inflammatory for any medical condition."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T140","span":{"begin":127,"end":153},"obj":"Disease"},{"id":"T141","span":{"begin":155,"end":161},"obj":"Disease"},{"id":"T142","span":{"begin":193,"end":216},"obj":"Disease"}],"attributes":[{"id":"A140","pred":"mondo_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/MONDO_0005265"},{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0005542"}],"text":"Clinically, the use of heparin as an anti-inflammatory agent has shown limited evidence of benefit in human diseases including inflammatory bowel disease, asthma, reactive airways disease, and acute coronary syndrome (13, 24). Despite this clinical evidence, heparin has not been approved by the US Federal Drug Administration as a direct anti-inflammatory for any medical condition."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T102","span":{"begin":61,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T103","span":{"begin":102,"end":107},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T104","span":{"begin":172,"end":179},"obj":"http://purl.obolibrary.org/obo/UBERON_0001005"},{"id":"T105","span":{"begin":267,"end":270},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T106","span":{"begin":330,"end":331},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Clinically, the use of heparin as an anti-inflammatory agent has shown limited evidence of benefit in human diseases including inflammatory bowel disease, asthma, reactive airways disease, and acute coronary syndrome (13, 24). Despite this clinical evidence, heparin has not been approved by the US Federal Drug Administration as a direct anti-inflammatory for any medical condition."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T194","span":{"begin":23,"end":30},"obj":"Chemical"},{"id":"T195","span":{"begin":37,"end":60},"obj":"Chemical"},{"id":"T196","span":{"begin":259,"end":266},"obj":"Chemical"}],"attributes":[{"id":"A194","pred":"chebi_id","subj":"T194","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A195","pred":"chebi_id","subj":"T195","obj":"http://purl.obolibrary.org/obo/CHEBI_67079"},{"id":"A196","pred":"chebi_id","subj":"T196","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"Clinically, the use of heparin as an anti-inflammatory agent has shown limited evidence of benefit in human diseases including inflammatory bowel disease, asthma, reactive airways disease, and acute coronary syndrome (13, 24). Despite this clinical evidence, heparin has not been approved by the US Federal Drug Administration as a direct anti-inflammatory for any medical condition."}

{"project":"LitCovid-sentences","denotations":[{"id":"T98","span":{"begin":0,"end":226},"obj":"Sentence"},{"id":"T99","span":{"begin":227,"end":383},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Clinically, the use of heparin as an anti-inflammatory agent has shown limited evidence of benefit in human diseases including inflammatory bowel disease, asthma, reactive airways disease, and acute coronary syndrome (13, 24). Despite this clinical evidence, heparin has not been approved by the US Federal Drug Administration as a direct anti-inflammatory for any medical condition."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T36","span":{"begin":127,"end":153},"obj":"Phenotype"},{"id":"T37","span":{"begin":155,"end":161},"obj":"Phenotype"},{"id":"T38","span":{"begin":163,"end":187},"obj":"Phenotype"}],"attributes":[{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0002037"},{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0002099"},{"id":"A38","pred":"hp_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"Clinically, the use of heparin as an anti-inflammatory agent has shown limited evidence of benefit in human diseases including inflammatory bowel disease, asthma, reactive airways disease, and acute coronary syndrome (13, 24). Despite this clinical evidence, heparin has not been approved by the US Federal Drug Administration as a direct anti-inflammatory for any medical condition."}

{"project":"2_test","denotations":[{"id":"32519894-31030744-2138198","span":{"begin":218,"end":220},"obj":"31030744"},{"id":"32519894-26064103-2138199","span":{"begin":222,"end":224},"obj":"26064103"}],"text":"Clinically, the use of heparin as an anti-inflammatory agent has shown limited evidence of benefit in human diseases including inflammatory bowel disease, asthma, reactive airways disease, and acute coronary syndrome (13, 24). Despite this clinical evidence, heparin has not been approved by the US Federal Drug Administration as a direct anti-inflammatory for any medical condition."}